Characterisation of Peptide5 systemic administration for treating traumatic spinal cord injured rats
Sign Up to like & getrecommendations! Published in 2017 at "Experimental Brain Research"
DOI: 10.1007/s00221-017-5023-3
Abstract: Systemic administration of a Connexin43 mimetic peptide, Peptide5, has been shown to reduce secondary tissue damage and improve functional recovery after spinal cord injury (SCI). This study investigated safety measures and potential off-target effects of… read more here.
Keywords: peptide5 systemic; spinal cord; systemic administration;